Analysis of PFS2 by subsequent therapy in KEYNOTE-361: Pembrolizumab (pembro) plus chemotherapy (chemo) or pembro alone versus chemo as 1L therapy for advanced urothelial carcinoma (UC).


ÖZGÜROĞLU M., Alva A. S. , Csoszi T., Matsubara N., Geczi L., Cheng S. Y. , ...More

JOURNAL OF CLINICAL ONCOLOGY, vol.39, no.6, 2021 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Abstract
  • Volume: 39 Issue: 6
  • Publication Date: 2021
  • Doi Number: 10.1200/jco.2021.39.6_suppl.448
  • Title of Journal : JOURNAL OF CLINICAL ONCOLOGY